Abnormalities of the CEBP alpha transcription factor: a major target in acute myeloid leukemia
- 1 April 2001
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 15 (4) , 688-689
- https://doi.org/10.1038/sj.leu.2402088
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001
- Upregulation of Interleukin 6 and Granulocyte Colony-Stimulating Factor Receptors by Transcription Factor CCAAT Enhancer Binding Protein α (C/EBPα) Is Critical for GranulopoiesisThe Journal of Experimental Medicine, 1998
- CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid ProgenitorsMolecular and Cellular Biology, 1998
- The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic DifferentiationMolecular and Cellular Biology, 1998
- Transcription Factors, Normal Myeloid Development, and LeukemiaBlood, 1997